WHO Expert Committee on Drug Dependence: Difference between revisions
No edit summary |
No edit summary |
||
| Line 24: | Line 24: | ||
* Prof. Jason White |
* Prof. Jason White |
||
* Suti Nudmamud Thanoi |
* Suti Nudmamud Thanoi |
||
==Meetings== |
|||
This list will only go as far back as the 40th Expert Committee on Drug Dependence Meeting. |
|||
'''46th Expert Committee on Drug Dependence Meeting:''' |
|||
The 46th Expert Committee meeting<ref>{{cite web |title=46th Expert Committee on Drug Dependence |url=https://www.who.int/groups/who-expert-committee-on-drug-dependence/46th-ecdd-documents |publisher=WHO}}</ref> was held on 16th Monday 2023, and reviewed 8 different drugs, such as: Benzodiazepines such as [[Bromazolam]] and [[Flubromazepam]], Novel synthetic [[Opioid|opioids]] such as [[Butonitazene]], [[Substituted cathinone|Cathinones]]/[[Stimulant|stimulants]] such as [[3-Chloromethcathinone|3-CMC]] and [[Dipentylone]], Dissociative-type substances such as [[2-Fluorodeschloroketamine|2-fluorodeschloroketamine]] as well as medicines such as [[Nitrous oxide (medication)|Nitrous Oxide (medication)]] and [[Carisoprodol]]. |
|||
==Substances Under Watchlist== |
|||
The ECDD currently have 25 drugs under their watchlist as of 2023<ref>{{cite web |title=LIST OF SUBSTANCES UNDER SURVEILLANCE 2023 |url=https://cdn.who.int/media/docs/default-source/46th-ecdd/2023_who_substances-under-surveillance.pdf?sfvrsn=7cdb47e6_1 |publisher=WHO ECDD}}</ref>, split into 7 different cateogories: [[Psychoactive drug|Psychoactive Medicines]], [[Substituted tryptamine|Tryptamines]], [[Opioid|Opioids]], [[Substituted cathinone|Synthetic cathinones]], [[Cannabinoid|Synthetic Cannabinoid Receptor Agonists]], [[Benzodiazepine|Benzodiazepines]] and [[Amphetamine type stimulant|Amphetamine-type stimulants]]. |
|||
==See Also== |
==See Also== |
||
Revision as of 14:24, 11 December 2023
| Parent institution | World Health Organization |
|---|---|
| Established | 1948 |
| Mission | Conducting the medical and scientific evaluation of drugs |
| Members | 11 |
| Website | ECDD Website |
The WHO Expert Committee on Drug Dependence (ECDD) is a committee within the World Health Organisation (WHO) that consists of a chosen group of independent experts within the field of pharmacology. This committee meets once a year in order to evaluate the effects of psychotic substances towards the public and the properties that cause the addictions, and considering the possible medical or therapeutic benefits and applications.[1]
Committee Members
This list is updated alongside the 2023 46th ECDD Committee Member List:[2]
- Prof. Patrick Beardsley
- Dr. Wim Best
- Dr. Sandra Comer
- Dr. Ifeoma Toyin Ekwere
- Dr. Simon Elliott
- Prof. Raka Jain
- Dr Pamela Kaduri
- Dr. Junichi Kitanaka
- Dr. Antonio Pascale Prieto
- Dr. Afarin Rahimi-Movaghar
- Prof. Jason White
- Suti Nudmamud Thanoi
Meetings
This list will only go as far back as the 40th Expert Committee on Drug Dependence Meeting.
46th Expert Committee on Drug Dependence Meeting: The 46th Expert Committee meeting[3] was held on 16th Monday 2023, and reviewed 8 different drugs, such as: Benzodiazepines such as Bromazolam and Flubromazepam, Novel synthetic opioids such as Butonitazene, Cathinones/stimulants such as 3-CMC and Dipentylone, Dissociative-type substances such as 2-fluorodeschloroketamine as well as medicines such as Nitrous Oxide (medication) and Carisoprodol.
Substances Under Watchlist
The ECDD currently have 25 drugs under their watchlist as of 2023[4], split into 7 different cateogories: Psychoactive Medicines, Tryptamines, Opioids, Synthetic cathinones, Synthetic Cannabinoid Receptor Agonists, Benzodiazepines and Amphetamine-type stimulants.
See Also
References
- ^ "46th ECDD Committee Member Biographies" (PDF). WHO.
- ^ "The WHO Expert Committee on Drug Dependence (ECDD)". WHO. 2023.
- ^ "46th Expert Committee on Drug Dependence". WHO.
- ^ "LIST OF SUBSTANCES UNDER SURVEILLANCE 2023" (PDF). WHO ECDD.